Conexeu Sciences Inc. Common Stock (CNXU) Stock Price

CNXUStock
$3.06
Market Cap$86.31M
P/E—
PEG Ratio—
Div yield—
Beta-1.24

CNXU Share Price Chart

Favorite Metrics

Price vs S&P 500 (4W)-34.25%
VGM Score7.91

CNXU Earnings Surprise History

QuarterReport dateEPS estimateEPS actualSurprise
Q2 2026-$0.10-$0.29-190.00%(-$0.19)

CNXU Analyst Recommendations

Jul 2026
Aug 2026
Sep 2026
4.14
4.14
4.14

Industry Peers — Orthopedic & Prosthetic Devices(31)

SymbolValue ScoreGrowth ScoreMomentum ScoreP/S Ratio (TTM)Revenue Growth (5Y)Gross Margin (TTM)Operating Margin (TTM)Price
CNXUConexeu Sciences Inc. Common Stock
——F————$3.06
ISRGIntuitive Surgical Inc.DBB13.7x18.2%66.7%31.3%$426.70
EWEdwards Lifesciences CorpDCB7.7x6.7%77.8%18.2%$86.60
STESTERIS plcCCB3.6x13.8%44.4%18.9%$222.66
ZBHZimmer Biomet Holdings, Inc.BCB2.1x3.2%69.9%14.2%$94.98
SNNSmith & Nephew plcBCC1.9x6.2%68.2%12.9%$29.06
ALGNAlign Technology IncBDC2.5x10.3%69.0%13.2%$147.31
MSAMine Safety IncorporatedCCB3.5x6.8%47.6%21.2%$179.05
ESTAEstablishment Labs Holdings Inc.FAC7.2x20.0%70.5%-7.6%$59.18
ENOVEnovis CorporationBDC0.5x-6.0%61.4%-45.1%$19.59
CDRECadre Holdings, Inc.BCC1.6x8.6%41.8%10.1%$26.38

About Conexeu Sciences Inc. Common Stock

Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.